Microsphere design for the colonic delivery of 5-fluorouracil (Q31150697)

29 June 2017

title

Microsphere design for the colonic delivery of 5-fluorouracil (English)

1 reference

29 June 2017

1 reference

1 reference

Alf Lamprecht

1

1 reference

29 June 2017

Hiromitsu Yamamoto

series ordinal

2

1 reference

29 June 2017

Hirofumi Takeuchi

series ordinal

3

1 reference

29 June 2017

Yoshiaki Kawashima

series ordinal

4

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Journal of Controlled Release

29 June 2017

published in

1 reference

29 June 2017

volume

90

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

313-322

1 reference

Treatment of colorectal cancer. Current guidelines and future prospects for drug therapy

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Disease management considerations: disease management considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Efficacy and toxicity of 5-fluorouracil and folates in advanced colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Calcium alginate beads as core carriers of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Design of microencapsulated chitosan microspheres for colonic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Development of biodegradable drug delivery system to treat addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900195-0

7 January 2021

10.1016/S0168-3659(03)00195-0

Identifiers

DOI

1 reference

29 June 2017

1 reference